Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:00 pm Sale | 2026-03-31 | 13G | ENVVENO MED CORP COM NVNO | PERCEPTIVE ADVISORS LLC | 68,525 9.990% | -1,979,990 (-96.65%) | Filing History |
| 2026-05-15 1:33 pm Sale | 2026-03-31 | 13G | ENVVENO MED CORP COM NVNO | Kingdon Capital Management, L.L.C. | 36,166 5.500% | -2,670 (-6.88%) | Filing History |
| 2026-02-20 09:43 am Unchanged | 2026-02-20 | 13D | ENVVENO MED CORP COM NVNO | Braeden Lichti | 33,151 5.050% | 0 (Unchanged) | Filing History |
| 2026-02-20 09:43 am Unchanged | 2026-02-20 | 13D | ENVVENO MED CORP COM NVNO | NorthStrive Fund II LP | 33,151 5.050% | 0 (Unchanged) | Filing History |
| 2026-02-17 4:00 pm Purchase | 2025-12-31 | 13G | ENVVENO MED CORP COM NVNO | PERCEPTIVE ADVISORS LLC | 2,048,515 9.990% | 1,995,109 (+3735.74%) | Filing History |
| 2026-02-10 4:29 pm Purchase | 2026-02-10 | 13G | ENVVENO MED CORP COM NVNO | NorthStrive Fund II LP | 33,151 5.050% | 33,151 (New Position) | Filing History |
| 2026-02-10 4:28 pm Purchase | 2026-02-10 | 13G | ENVVENO MED CORP COM NVNO | Braeden Lichti | 33,151 5.050% | 33,151 (New Position) | Filing History |
| 2025-11-19 4:08 pm Purchase | 2025-11-14 | 13G | ENVVENO MED CORP COM NVNO | Thomas A. Satterfield, Jr. | 52,071 9.000% | 52,071 (New Position) | Filing History |
| 2025-11-14 4:40 pm Sale | 2025-09-30 | 13G | ENVVENO MED CORP COM NVNO | Nantahala Capital Management, LLC | 19,684 3.460% | -17,055 (-46.42%) | Filing History |
| 2025-09-09 12:58 pm Purchase | 2025-09-02 | 13G | ENVVENO MED CORP COM NVNO | Kingdon Capital Management, L.L.C. | 38,836 7.100% | 38,836 (New Position) | Filing History |
| 2024-11-14 4:53 pm Sale | 2024-09-30 | 13G | ENVVENO MED CORP COM NVNO | Nantahala Capital Management, LLC | 36,739 7.056% | -3,249 (-8.12%) | Filing History |
| 2024-11-14 4:50 pm Purchase | 2024-09-30 | 13G | ENVVENO MED CORP COM NVNO | PERCEPTIVE ADVISORS LLC | 53,406 9.900% | 13,557 (+34.02%) | Filing History |
| 2024-02-23 4:16 pm Unchanged | 2024-02-23 | 13G | ENVVENO MED CORP COM NVNO | PERCEPTIVE ADVISORS LLC | 39,849 9.900% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:51 pm Purchase | 2023-12-31 | 13G | ENVVENO MED CORP COM NVNO | Nantahala Capital Management, LLC | 39,988 9.900% | 39,988 (New Position) | Filing History |
| 2024-02-14 4:38 pm Purchase | 2023-12-31 | 13G | ENVVENO MED CORP COM NVNO | PERCEPTIVE ADVISORS LLC | 39,849 9.900% | 13,063 (+48.77%) | Filing History |
| 2023-02-14 2:31 pm Sale | 2022-12-31 | 13G | ENVVENO MED CORP COM NVNO | PERCEPTIVE ADVISORS LLC | 26,786 9.900% | -478 (-1.75%) | Filing History |
| 2022-02-14 4:38 pm Unchanged | 2021-12-31 | 13G | ENVVENO MED CORP COM NVNO | PERCEPTIVE ADVISORS LLC | 27,264 9.900% | 0 (Unchanged) | Filing History |
| 2022-02-14 3:28 pm Sale | 2021-12-31 | 13G | ENVVENO MED CORP COM NVNO | CVI Investments, Inc. | 8,010 2.900% | -4,439 (-35.66%) | Filing History |
| 2022-02-11 07:39 am Purchase | 2021-12-31 | 13G | ENVVENO MED CORP COM NVNO | Mitchell P. Kopin | 12,320 4.400% | 6,851 (+125.27%) | Filing History |
| 2022-01-19 11:03 am Sale | 2021-12-31 | 13G | ENVVENO MED CORP COM NVNO | Empery Asset Management LP | 13,474 4.740% | -2,853 (-17.47%) | Filing History |